Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Long-term Safety and Efficacy of a Tacrolimus-based 5-day Steroid Rapid Withdrawal Immunoprophylactic Regimen in de Novo Renal Transplantation

NCT00133172 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00133172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Long-term Safety and Efficacy of a Tacrolimus-based 5-day Steroid Rapid Withdrawal Immunoprophylactic Regimen in de Novo Renal Transplantation
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2005
Completion date
March 31, 2007
Enrollment
85 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation